FOLH1 and prostate carcinoma: Immunotherapy (Figure 3) can also be used to treat prostate cancer, as prostate cancer cells commonly express on their surface several altered antigens, including prostate-specific antigen (PSA), PSMA, or prostatic acid phosphatase (PAP) [67].